GoHealth, Inc.

Listed Company

GOCOCIK 0001808220NasdaqNon-AcceleratedSmaller ReportingInsurance Agents, Brokers & ServiceDelawareFY ends Dec 31

Period

FY 2025

Revenue

—

Net Income

$-257.13M

Total Assets

$987.38M

Equity

$37.87M

Shares Out

1.0K

Op. Cash Flow

$-121.95M

Business

GoHealth, Inc. is a health insurance marketplace and Medicare-focused digital health company that provides technology-enabled education, plan comparison, agent-assisted enrollment and ongoing consumer support for Medicare-eligible individuals. It primarily offers Medicare Advantage, Medicare Supplement, prescription drug plans and Special Needs Plans, and provides enrollment, plan administration, onboarding and post-enrollment engagement services. Its operations center on the Encompass operating model and a proprietary platform — including LeadScore, PlanFit, Marketplace and Customer360 — and generate agency and non-agency revenue. GoHealth partners with health plans across all 50 states and the District of Columbia and acquires consumers via omnichannel marketing, digital channels, telesales, marketing partners and a remote agent network.

Summary from filing dated 2025-02-27

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Net revenues	362	799	735	632	1,062
Revenue share	96	131	159	188	239
Marketing and advertising	116	236	205	208	365
Consumer care and enrollment	106	222	209	261	319
Technology	35	41	43	46	48
General and administrative	91	82	93	117	98
Amortization of intangible assets	71	94	94	94	94
Indefinite and long-lived asset impairment charges	260	0	13	—	—
Total operating expenses	775	806	816	950	1,552
Income (loss) from operations	−413	−7	−82	−319	−489
Interest expense	87	73	69	57	—
Gain on bargain purchase	0	−85	0	0	—
Loss on extinguishment of debt	2	10	0	0	12
Other (income) expense, net	−786,000	−834,000	−37,000	−115,000	−669,000
Income (loss) before income taxes	−501	−5	−151	−376	−534
Income tax expense (benefit)	−3	2	154,000	764,000	−24,000
Net income (loss)	−498	−7	−151	−376	−534
Net income (loss) attributable to noncontrolling interests	−241	−4	−88	−228	−345
Net income (loss) attributable to GoHealth, Inc.	−257	−3	−63	−149	−189
Net income (loss) per share of Class A common stockbasic (in dollars per share)	−20.17	−0.66	−7.19	−17.72	−26.8
Net income (loss) per share of Class A common stockdiluted (in dollars per share)	−20.17	−0.66	−7.19	−17.72	−26.8
Weighted-average shares of Class A common stock outstandingbasic (in shares)	13	10	9	8	7
Weighted-average shares of Class A common stock outstandingdiluted (in shares)	13	10	9	8	7

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Cash and cash equivalents	33	41	91	16	84
Accounts receivable, net of allowance for doubtful accounts of $5 in 2025 and $1 in 2024	72,000	4	250,000	5	17
Commissions receivable - current	240	320	336	336	269
Prepaid expense and other current assets	13	35	49	58	59
Total current assets	286	400	476	415	429
Commissions receivable - non-current	686	733	575	696	994
Operating lease ROU asset	10	19	22	21	23
Property, equipment, and capitalized software, net	5	29	27	25	24
Intangible assets, net	0	302	397	501	595
Other long-term assets	1	4	2	2	4
Total assets	987	1,488	1,500	1,659	2,069
Accounts payable	7	15	18	15	40
Accrued liabilities	35	121	86	53	53
Commissions payable - current	64	99	127	122	104
Short-term operating lease liability	7	6	6	9	6
Deferred revenue	25	54	52	51	536,000
Current portion of long-term debt	0	40	75	5	5
Other current liabilities	3	4	6	10	8
Total current liabilities	142	338	370	265	217
Commissions payable - non-current	157	178	203	253	274
Long-term operating lease liability	29	35	40	38	20
Long-term debt, net of current portion	637	448	423	505	665
Deferred tax liability	19	22	0	—	—
Other non-current liabilities	11	9	9	6	0
Total non-current liabilities	851	692	675	802	959
Commitments and Contingencies (Note 12)	—	—	—	—	—
Preferred stock	0	0	0	0	0
Additional paid-in capital	728	669	654	626	561
Accumulated other comprehensive income (loss)	−59,000	−151,000	−127,000	−144,000	−59,000
Accumulated deficit	−680	−423	−420	−357	−208
Total stockholders equity attributable to GoHealth, Inc.	38	242	231	269	353
Non-controlling interests	−100	164	175	274	539
Total stockholders equity (deficit)	−62	405	406	542	892
Total liabilities, redeemable convertible preferred stock and stockholders equity (deficit)	987	1,488	1,500	1,659	2,069

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Share-based compensation	9	11	20	27	27
Depreciation and amortization	10	12	12	13	13
Amortization of debt discount and issuance costs	8	9	3	3	2
Deferred tax liability	−4	4	0	0	—
Non-cash lease expense	3	4	4	4	5
Other non-cash items, net	−346,000	3,000	−902,000	−250,000	−5,000
Accrued interest payable in kind	39	0	0	—	—
Accounts receivable	4	−2	5	13	−3
Commissions receivable	128	−51	120	231	−453
Prepaid expenses and other assets	23	15	8	2	−19
Accounts payable	−8	−5	3	−25	30
Accrued liabilities	−87	28	33	546,000	26
Deferred revenue	−28	1	2	50	−200,000
Commissions payable	−56	−46	−48	−3	117
Operating lease liabilities	−3	−6	−9	−7	−5
Other liabilities	5	−9	3	7	−721,000
Net cash provided by (used in) operating activities	−122	−22	109	61	−299
Acquisition of business, net	0	18	0	0	—
Purchases of property, equipment and software	−8	−14	−14	−14	−20
Net cash (used in) provided by investing activities	−8	4	−14	−14	−20
Proceeds from borrowings	138	558	0	0	565
Repayment of borrowings	−2	−556	−15	−160	−299
Payment of debt discount and issuance costs	−8	−33	0	−3	−4
Repurchase of shares to satisfy employee tax withholding obligations	−5	−2	−2	−345,000	0
Proceeds from stock option exercises	1,000	399,000	91,000	5,000	0
Payment of preferred stock dividends	0	0	−4	0	0
Net cash provided by (used in) financing activities	122	−32	−21	−115	259
Effect of exchange rate changes on cash and cash equivalents	182,000	−55,000	42,000	−238,000	−155,000
Increase (decrease) in cash and cash equivalents	−8	−50	74	−68	−60
Interest paid	46	66	55	57	28
Income taxes paid	432,000	416,000	548,000	486,000	879,000
Purchases of property, equipment and software included in accounts payable	0	252,000	2,000	123,000	633,000

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro